ABEJA

Welcome to the Brand page for “ABEJA”, which is offered here for Pharmaceuticals, proteins, antibodies, and large molecules for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system related diseases and disorders, and infectious diseases, blood disorders, obesity, and cognitive disorders; none of the foregoing including external use pain reliever preparations, ointments, and liniments;the english translation of abeja in the mark is bee.;medical research and scientific research information in the field of the production of proteins, antibodies, and large molecules; none of the foregoing relating to external use pain reliever preparations, ointments, and liniments;.

Its status is currently believed to be active. Its class is unavailable. “ABEJA” is believed to be currently owned by “Vir Biotechnology, Inc.”